MR spectroscopy with MRI helps pinpoint return of prostate cancer

08/4/2010 | (free registration)

Adding magnetic resonance spectroscopy to T2-weighted MRI greatly improved the accuracy of the latter method in diagnosing recurrent prostate cancer after external-beam radiation therapy, researchers said. The added data provided by MR spectroscopy could help physicians determine the patients who would benefit from targeted prostateside biopsies, the researchers also said.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX